Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
US economy, Indian rupee and more... - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • May 7, 2008

    US economy, Indian rupee and more...

    US economy sinking
    While talks about the US economy sinking into a recession have been doing the rounds for quite some while now, latest economic reports released seem to suggest that the economy, though tethering on the edge, is managing to hold on. While the Federal Reserve has cut interest rates to 2%, there is a possibility that there could be a pause in any further cuts given that inflation induced by rising oil and food prices refuses to abate soon. The Economist states that as per the initial GDP estimates, output grew at an annualised rate of 0.6% in the period January to March 2008, which was higher than estimates. The weaker dollar, also, to a certain extent has helped matters. US companies deriving revenues from overseas markets are enjoying the fruits of a rise in profitability. In fact, as per the magazine, excluding oil, America's current account deficit has shrunk to an eight year low of 2.4% of GDP. Besides this, for the first time in the last four months, the non-farm payrolls has shown only 20,000 job cuts as against the forecasted drop of 75,000. All these factors sparked a rally in the dollar, which has received a battering in the past one year.

  • Is the US economy on thin ice?

    Indian Rupee depreciating
    The Indian rupee has gradually depreciated to Rs 40.58 per US dollar prompted by the rise in the greenback and the pressure on the currency towards the end of the month when oil importers look to make payments. The other factor, which has been weighing heavy on the rupee, is the burgeoning trade deficit, which widened to US$ 72.5 bn during the period April 2007 to February 2008, reflecting a 47% YoY growth. Sharp rise in the non-oil imports has resulted in India's overall imports growing faster than exports during 2007-08. Having said that, robust 39% YoY growth in invisibles (trade in services, transfers and income from overseas assets) ensured that the current account deficit was capped at US$ 16 bn.

  • What makes the rupee weak?

    Downside of R&D in Pharma
    A leading business daily reported that India's second largest pharma company, Dr. Reddy's has discontinued R&D on its cardiovascular drug. This drug was part of the four compounds that were transferred to Perlecan Pharma, an integrated drug development company formed by Dr. Reddy's in FY06. One other molecule focusing on the therapeutic area of diabetes has also been discontinued, which effectively means that Perlecan now has two molecules as compared to the four that it had started out with. While Dr. Reddy's lead molecule 'Balaglitazone' has been progressing well in clinical trials, it belongs to a class of drugs which have faced safety issues in the past prompting the US FDA to be more stringent while approving these drugs. Case in point is GSK Plc's anti-diabetic drug 'Avandia', which was reported to increase the rate of heart attacks.

    These developments highlight the risks and uncertainty associated with R&D, which though when successful can enhance revenues and profits, can also dampen profitability when a particular drug fails to advance further in clinical trials. It may be noted that besides Dr. Reddy's, other domestic companies such as Sun Pharma, Nicholas Piramal, Ranbaxy and Wockhardt have also hived off their R&D units into separate companies. What separates Dr. Reddy's from its peers is the fact that the former has roped in private capital from Citigroup and ICICI Ventures, while the others are planning to list the hived off R&D entities on the Indian bourses. Whether this development will push Dr. Reddy's to mirror the strategy of its peers remains to be seen.



    Equitymaster requests your view! Post a comment on "US economy, Indian rupee and more...". Click here!


    More Views on News

    How to Ride Alongside India's Best Fund Managers (The 5 Minute Wrapup)

    Jun 10, 2017

    Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.

    Why NOW Is the WORST Time for Index Investing (The 5 Minute Wrapup)

    Aug 18, 2017

    Buying the index now will hardly help make money in stocks even in ten years.

    Trump Takes a Beating (Vivek Kaul's Diary)

    Aug 18, 2017

    Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.

    How To Read Your Mutual Fund Account Statement Correctly (Outside View)

    Aug 17, 2017

    PersonalFN simplifies the mutual fund account statement for you.

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process) (The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 18, 2017 (Close)